111 Capital’s Clorox CLX Stock Holding History

111 Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,589	Closed	-$1.1M	–	513
2026 Q1	$1.1M	Buy	+10,589	New	+$1.2M	0.27%	72
2025 Q3	–	Sell	-1,792	Closed	-$215K	–	500
2025 Q2	$215K	Sell	1,792 -1,863	-51%	-$249K	0.04%	437
2025 Q1	$538K	Buy	+3,655	New	+$558K	0.1%	210

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

111 Capital's CLX Position: Q2 2026 in Review

111 Capital sold out of Clorox (CLX) in Q2 2026, closing a stake of 10,589 shares — an estimated $1.1M sold.

111 Capital first reported a position in CLX in Q1 2025 and held it in 3 quarters. The position peaked at $1.1M in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

111 Capital reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
111 Capital sold 10,589 Clorox shares in Q2 2026, an estimated $1.1M.
111 Capital first reported a position in Clorox in Q1 2025 and held it in 3 quarters.
111 Capital's Clorox position peaked at $1.1M in Q1 2026.
1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.